Literature DB >> 7490100

Molecular cloning and chromosomal mapping of the mouse cyclin-dependent kinase 5 gene.

T Ohshima1, J W Nagle, H C Pant, J B Joshi, C A Kozak, R O Brady, A B Kulkarni.   

Abstract

Cyclin-dependent kinase 5 (Cdk5) is predominantly expressed in neurons. In vitro, Cdk5 purified from the nervous tissue phosphorylates both high-molecular-weight neurofilament and microtubule-associated tau. The mouse gene encoding Cdk5 (Cdk5) was found to be 5 kb in length and divided into 12 exons. All of the exon-intron junctions matched the expected consensus sequence with the exception of the splice junction for intron 9, which has AT and AC dinucleotides instead of the usual GT and AG bordering sequence. In the 5'-flanking region of mouse Cdk5, several putative promoter elements were present, including AP1, Sp1, PuF, and TATA motifs. A metal regulatory element was also identified at position -207 to -201. Nucleotide sequence analysis of mouse Cdk5 showed high identity to the homologues of other vertebrate species, indicating that this kinase is highly conserved during evolution. Mouse Cdk5 was mapped to the centromeric region of mouse chromosome 5.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490100     DOI: 10.1006/geno.1995.1194

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  11 in total

1.  Role of the 3' splice site in U12-dependent intron splicing.

Authors:  R C Dietrich; M J Peris; A S Seyboldt; R A Padgett
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

Review 2.  AT-AC pre-mRNA splicing mechanisms and conservation of minor introns in voltage-gated ion channel genes.

Authors:  Q Wu; A R Krainer
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

3.  Loss in efficacy measures of tolfenamic acid in a tau knock-out model: Relevance to Alzheimer's disease.

Authors:  Allison Leso; Syed W Bihaqi; Anwar Masoud; Joanna K Chang; Asma Lahouel; Nasser Zawia
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-26

4.  Tolfenamic acid reduces tau and CDK5 levels: implications for dementia and tauopathies.

Authors:  Lina Adwan; Gehad M Subaiea; Riyaz Basha; Nasser H Zawia
Journal:  J Neurochem       Date:  2014-10-18       Impact factor: 5.372

5.  Migration defects of cdk5(-/-) neurons in the developing cerebellum is cell autonomous.

Authors:  T Ohshima; E C Gilmore; G Longenecker; D M Jacobowitz; R O Brady; K Herrup; A B Kulkarni
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

6.  The Genexpress IMAGE knowledge base of the human brain transcriptome: a prototype integrated resource for functional and computational genomics.

Authors:  G Piétu; R Mariage-Samson; N A Fayein; C Matingou; E Eveno; R Houlgatte; C Decraene; Y Vandenbrouck; F Tahi; M D Devignes; U Wirkner; W Ansorge; D Cox; T Nagase; N Nomura; C Auffray
Journal:  Genome Res       Date:  1999-02       Impact factor: 9.043

7.  Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death.

Authors:  T Ohshima; J M Ward; C G Huh; G Longenecker; H C Pant; R O Brady; L J Martin; A B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Neuronal cyclin-dependent kinase 5 activity is critical for survival.

Authors:  T Tanaka; T Ohshima; P Rajan; N D Amin; A Cho; T Sreenath; H C Pant; R O Brady; A B Kulkarni
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

9.  Perinatal abrogation of Cdk5 expression in brain results in neuronal migration defects.

Authors:  Motoyuki Hirasawa; Toshio Ohshima; Satoru Takahashi; Glenn Longenecker; Yasuyuki Honjo; Harish C Pant; Katsuhiko Mikoshiba; Roscoe O Brady; Ashok B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

10.  Mithramycin A Alleviates Cognitive Deficits and Reduces Neuropathology in a Transgenic Mouse Model of Alzheimer's Disease.

Authors:  Chao Wei; Wei Zhang; Qiong Zhou; Chao Zhao; Ying Du; Qi Yan; Zhuyi Li; Jianting Miao
Journal:  Neurochem Res       Date:  2016-04-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.